Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Protocol ID
ASCT2031
Disease (Sub Disease)
Leukaemia
Myelodysplastic Syndrome
Diagnosis Stage
Newly diagnosed
Location
NSW
Sponsor
Children's Oncology Group
Trial Status
Open
Sites
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 3
Age Eligibility
6 Months to 22 Years
International registry ID's
NCT05457556
Back to Registry
Study Title A Multi-Center Phase 3 Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children Adolescents and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Protocol ID ASCT2031
Disease (Sub Disease) Leukaemia
Myelodysplastic Syndrome
Diagnosis Stage Newly diagnosed
Location NSW
Sponsor Children's Oncology Group
Links https://clinicaltrials.gov/ct2/show/NCT05457556
Trial Status Open
Trial Open Date 12/12/2023
Sites The Children's Hospital at Westmead
Study Type Treatment
Phase Phase 3
Age Eligibility 6 Months to 22 Years
International registry ID's NCT05457556